Immunity for Health 2017
On October 20th 2017 Immunity for health is happy to host its second edition of “Immunity for Health”: the Immunity for health annual flagship event where all stakeholders, both from the human and animal health sector, working in the field of immunology, vaccinology, immune-oncology and infectious diseases are invited to meet, interact and start collaborations.
The theme of this year’s edition is “Learning the rules of the immune system: a translational approach“. We are honoured to welcome some internationally renowned experts in the field and are looking forward to be inspired by their talks!
Venue: Elzenveld, Lange Gasthuisstraat 45, 2000 Antwerpen (Attention! Leien closed in both directions: click here to plan your route to Antwerp)
Registration starts at 8:00.
Programme – October 20th, 2017:
OPENING SESSION – Orchestrating immune responses in humans and animals to prevent and treat disease – many challenges, one health (Auditorium)
Chair: Sven Arnouts, Chairman of the Board, Immunity for health
08:45 WELCOME
09:00 OPENING KEYNOTE I – Vaccination strategies from a “One Health” perspective
Ab Osterhaus, Director Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Germany
09:30 KEYNOTE II – Systems Vaccinology: Enabling rational vaccine design with systems biological approaches
Helder Nakaya, Assistant Professor University of Sao Paulo, Brazil and Adjunct Professor of Emory University, USA
10:00 KEYNOTE III – Using dendritic cells as immune orchestrators for therapeutic vaccination of cancer patients
Evelien Smits, Professor Tumor Immunology, University of Antwerp & Antwerp University Hospital
10:30 COFFEE BREAK (Looking for a sponsorship opportunity? Please contact us!)
MORNING SESSION II – Enhancing the value of clinical trials starts with sharing data & experiences – let’s do so (Auditorium)
Chair: Pierre Van Damme, Immunity for health track lead Clinical trials
Discussion panel: Evelien Smits, Timo Vesikari (tbc), Corinne Vandermeulen
10:50 Clinical trials: State of play at EU and national level
Greet Musch, Director General PRE Authorisation, FAMHP
11:10 University of Tampere Vaccine Research Center: Concept and Achievements
Timo Vesikari, Director Vaccine Research Center, University of Tampere, Finland
11:40 Pitch your clinical research – vaccines & immunotherapeutics
11:40 CriPec® Nanomedicines for Superior Therapeutic Performance
Dr. Marielle Thewissen, senior scientist translational medicine, Cristal Therapeutics
11:50 Next generation immunotherapeutics
Pierre Vandepapelière, CEO & CMO, Imcyse
12:00 Myasterix, an immunotherapy for myasthenia gravis
Nicolas Havelange, Chief Operating Officer, Curavac
12:10 short panel discussion
12:20 LUNCH
AFTERNOON SESSION I: The power of the porcine immune system – learning from different worlds (Auditorium)
Chair: Hugo Van Heuverswyn, Immunity for health track lead R&D
13:50 Comparative pig, mouse and human immunomics; similarities, peculiarities and priorities
Harry Dawson, Senior Research Scientist USDA/ARS, Beltsville Human Nutrition Research Center, USA
14:20 Therapeutic vaccine development in the porcine model
Gregers Jungersen, Professor Adaptive Immunology and Vaccinology, National Veterinary Institute, Technical University of Denmark
14:50 R&D track launches call for action + Pitch your collaboration incentive
Hugo van Heuverswyn, Member of the Board, Immunity for health
15:30 COFFEE BREAK
CLOSING SESSION: Fostering innovation & developing new preventive and therapeutic tools takes joint efforts (Auditorium)
Chair: Henk Joos, Immunity for health track Regional & International visibility
15:50 Human Vaccines Project: accelerate development of vaccines and immunotherapies by decoding the immune system
Georges Thiry, PhD, PMP, Consultant, representing the Human Vaccines Project
16:10 Overview of the Vaccine landscape in Belgium
Stéphanie Mali, Coordinator Center of Excellence for Vaccines, FAMHP
Laurence Timmermans, International affairs, BioWin
16:30 CLOSING KEYNOTE IV – Perspectives of a young female cancer survivor on the importance of health awareness
Stefanie Veraghtert, Project Officer at “Kom op tegen Kanker” and founder of Big C – Coffee for Cancer
17:00 Closing remarks
Sven Arnouts, Chairman of the Board, Immunity for health
17:10 NETWORKING RECEPTION
Our members & strategic partners
Organizations with expertise in immunology, oncology, vaccinology and infectious diseases, are invited to join Immunity for Health. Together, we build a strong network, fostering innovation in diagnostics, medical devices, immunotherapeutics, and vaccines for humans and animals and across the entire value chain—from R&D to manufacturing, supply, marketing, and beyond. Join us to make impact!
